Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01957111 · ClinicalTrials.gov registry record

Metabolomics of Insomnia-Related Hyperarousal

A clinical trial of Primary Insomnia, sponsored by University of Pennsylvania.

Completed
Registry status
32
Enrollment target
1
Study location

NCT01957111 is a study of Primary Insomnia that has completed, run by University of Pennsylvania. The registered enrollment target is 32 participants, below the 123-participant average among 12 other Primary Insomnia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01957111, a study of Primary Insomnia, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
32 participants
Enrollment target
1
Study location

Study Summary

Individuals with insomnia have been shown to have higher overall metabolic rates compared to good sleepers, but it is not known which metabolic processes are involved. The goal of this study is to compare a wide array of metabolic processes in 15 people with insomnia and 15 good sleepers. We hypothesize that there will be distinct metabolic processes that are functioning differently in those with insomnia.

Conditions Studied

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2013-10
Est. Completion 2015-10

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01957111

The ClinicalTrials.gov registry entry for NCT01957111 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 123-participant average among 12 other Primary Insomnia trials with a reported enrollment target (74% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Primary Insomnia appearing as the primary indexed condition, and to 0 interventions.

NCT01957111 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01957111 about?

NCT01957111 is a clinical study titled "Metabolomics of Insomnia-Related Hyperarousal". Individuals with insomnia have been shown to have higher overall metabolic rates compared to good sleepers, but it is not known which metabolic processes are involved. The goal of this study is to compare a wide array of metabolic processes in 15 people with insomnia and 15 good sleepers. We hypothe...

What is the current status of trial NCT01957111?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2013-10. Estimated completion is 2015-10.

What conditions does trial NCT01957111 study?

This clinical trial studies the following conditions: Primary Insomnia.

Who is sponsoring clinical trial NCT01957111?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01957111 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Primary Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.